The results show that alpinetin reduced ROS production, resulting in reduced ROS/NF‐Κb/HIF‐1α pathway activity, which leads to impaired cell proliferation and induction of mitochondria‐associated apoptosis, culminating in reduced tumour growth (Figure 6). The gene discussed is HIF1A; the disease is neoplasm.